EER-28462-13303
3 vaccinations
1 coded response
20 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 352 / AL
- Registered
- 2020-12-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-19
Registered in v-safe
-
2020-12-20
Dose 1 — Pfizer-BioNTech
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-27
- 2021-01-03
-
2021-01-10
Dose 2 — Pfizer-BioNTech
- 2021-01-10
- 2021-01-14
- 2021-01-15
- 2021-01-16
- 2021-01-17
- 2021-01-24
- 2021-01-31
- 2021-02-07
- 2021-02-14
- 2021-02-21
- 2021-04-11
- 2021-07-11
-
2021-12-03
Dose 3 — Moderna
- 2022-01-10
-
2022-06-03
Survey response — 6 months, dose 3MedDRA: Chills, Malaise, Myalgia, Nasal congestion, Pyrexia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Nasal congestion, malaise, chills, fever, myalgiasMedDRA releases: 2024-11 · check-in free text available
-
2022-06-03
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-06-06
Call successfulParticipant prefers to complete VAERS report online
- 2022-12-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-20 | Pfizer-BioNTech | |
| 2 | 2021-01-10 | Pfizer-BioNTech | |
| 3 | 2021-12-03 | Moderna | No |
Call center
1 call center case
1 successful
Free text
Release 11 — 6 months, dose 3
Symptoms: Nasal congestion, malaise, chills, fever, myalgias
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | · | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release